Skip to main content
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
31.16
+0.11 (0.35%)
At close: Apr 28, 2026, 4:00 PM EDT
31.16
0.00 (0.00%)
Pre-market: Apr 29, 2026, 8:04 AM EDT

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
2.08
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Innoviva 411.33M
Vericel 276.26M
AnaptysBio 234.60M
Recursion Pharmaceuticals 74.68M
Nurix Therapeutics 71.78M
Nuvation Bio 62.90M
Taysha Gene Therapies 9.77M
Revenue Rankings

HRMY News

More News